Fingolimod

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Fingolimod and local guidelines before prescribing.

S1P receptor modulator

Mechanism

Sphingosine-1-phosphate receptor modulator trapping lymphocytes in nodes.

Uses

Relapsing multiple sclerosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

First-dose bradycardia, macular oedema, infections, raised LFT, skin cancers.

Interactions

Beta-blockers, QT-prolonging drugs; live vaccines.

Contraindications and cautions

Heart block, recent MI, active infection

Monitoring

ECG, LFT, eye check, FBC

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Observe at first dose with ECG and BP for 6 hours; check varicella immunity.

More from the textbook: uses, cautions and other points
Where it is discussed in the book